COR Cortex Pharmaceuticals,

Cortex Pharmaceuticals, Inc. (NYSE Alternext US (COR)) President and CEO, Mark A. Varney, Ph.D., will present at Rodman & Renshaw�s Tenth Annual Healthcare Conference taking place November 10 - 12, 2008, at the New York Palace Hotel. Dr. Varney will give the Company presentation on Monday, November 10 at 11:10 AM (EST) in the Holmes II Room. Additional information regarding the conference can be found at http://www.rodmanandrenshaw.com/conferences?id=19. Dr. Varney will provide a brief corporate overview as well as an update on the Company�s latest clinical developments, including recently reported positive top-line data from its second Phase IIa study in opioid-induced respiratory depression with the AMPAKINE� compound CX717. CX717 achieved statistical significance (p = 0.005) over placebo on the primary endpoint measure of spontaneous basal respiration without affecting opioid-induced analgesia. To access a live audio webcast or the subsequent archived recording, log on to http://www.wsw.com/webcast/rrshq14/cor. Please connect to the website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary. An archive of the replay will be available for ninety days at http://www.cortexpharm.com. Cortex Pharmaceuticals, Inc. Cortex, located in Irvine, California, is a neuroscience company focused on novel drug therapies for treating psychiatric disorders, neurological diseases and brain mediated breathing disorders. Cortex is pioneering a class of proprietary pharmaceuticals called AMPAKINE compounds, which act to increase the strength of signals at connections between brain cells. The loss of these connections is thought to be responsible for memory and behavior problems in Alzheimer�s disease. Many psychiatric diseases, including schizophrenia, occur as a result of imbalances in the brain�s neurotransmitter system. These imbalances may be improved by using the AMPAKINE technology. For additional information regarding Cortex, please visit Cortex Pharmaceuticals� website at http://www.cortexpharm.com.